Episode 1 - Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights a...

Episode 2 - Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights a...Подробнее

Episode 3 - Talking TNBC: Advancing Treatment in Triple Negative Breast Cancer: Latest Insights a...Подробнее

Targeting Advanced Triple-Negative Breast Cancer | Dana-Farber Cancer InstituteПодробнее

Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical StrategiesПодробнее

Triple Negative Breast Cancer (TNBC): Treatment Options and What to ExpectПодробнее

Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical StrategiesПодробнее

Advancing Treatment in Triple Negative Breast Cancer: Latest Insights and Clinical StrategiesПодробнее

Insights from the PROMENADE study on ER-low triple-negative breast cancerПодробнее

What makes a triple negative breast cancer negative Reis Filho 1Подробнее

Triple Negative Breast Cancer (TNBC) | Dr Rachel DearПодробнее

Breast Cancer Trials Q&A: Triple Negative Breast CancerПодробнее

Review of Recent Progress in Immunotherapy in Triple Negative Breast Cancer Schmid 1Подробнее

Triple Negative Breast Cancer Update with Dr. Gregory Vidal and the TNBC Foundation, January 2023Подробнее

Management for residual disease in TNBC after Chemo-ImmunotherapyПодробнее

DORA: durvalumab and olaparib in platinum treated advanced TNBCПодробнее

Future Directions for Treatment of TNBCПодробнее

The emerging role of immunotherapy for the treatment of early and advanced breast cancerПодробнее

BEGONIA: durvalumab combinations in advanced TNBCПодробнее

New Insights for Breast CancerПодробнее